Research Explorer

Uw browser ondersteunt geen JavaScript of JavaScript is niet ingeschakeld. Zonder JavaScript kan sommige functionaliteit van deze webapplicatie uitgeschakeld zijn of foutmeldingen veroorzaken. Raadpleeg om JavaScript in te schakelen de handleiding van uw browser of contacteer uw systeembeheerder.

Onderzoeker

Asif Hameed Khan

Prijzen & Erkenningen

95 Resultaten

2024

Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis

Claus BachertPhilippe GevaertBrian LipworthSyed Shahzad MustafaAndrew P. LaneJoaquim MullolPaul RoweYamo DenizSiddhesh KamatAsif H. Khan et al.

A1 Artikel in een tijdschrift in ALLERGY

2022

AROMA : real-world global registry of dupilumab for chronic rhinosinusitis with nasal polyps

Shahid SiddiquiClaus BachertAdam M. ChakerJoseph K. HanPeter HellingsAnju T. PetersEnrico HefflerSiddhesh KamatHaixin ZhangScott Nash et al.

A1 Artikel in een tijdschrift in ERJ OPEN RESEARCH

Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD) : measurement properties of novel patient-reported symptom measures

Adam GaterLinda NelsenCheryl D CoonSonya EremencoSean O’QuinnAsif H. KhanLaurent EckertHannah StauntonNicola BonnerRebecca Hall et al.

A1 Artikel in een tijdschrift in JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

Chronic rhinosinusitis : natural history, impact on health-related quality of life, and patient perspectives

Asif H. KhanClaus BachertThibaut Van Zele

Development of Sinonasal Outcome Test (SNOT-22) domains in chronic rhinosinusitis with nasal polyps

Asif H. KhanMatthew ReaneyIsabelle GuilleminLauren NelsonShanshan QinSiddhesh KamatLeda MannentNikhil AminDiane WhalleyClaire Hopkins

A1 Artikel in een tijdschrift in LARYNGOSCOPE

Dupilumab achieves durable reduction in severity of symptoms rated most important by patients with chronic rhinosinusitis with nasal polyps

Claire HopkinsStella LeeWytske FokkensEugene ChangJérôme MsihidAsif H. KhanUrvi MujumdarSiddhesh KamatScott NashShahid Siddiqui et al.

Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases

G Walter CanonicaArnaud BourdinAnju T PetersMartin DesrosiersClaus BachertStephan WeidingerEric L SimpsonNadia DaizadehZhen ChenSiddesh Kamat et al.

A1 Artikel in een tijdschrift in JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps : association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials

Claus BachertJonathan CorrenStella E. LeeHaixin ZhangSivan HarelDanen CunoosamyAsif H. KhanJuby A. Jacob‐NaraShahid SiddiquiScott Nash et al.

Redactioneel materiaal

Dupilumab improves asthma control, and allergic rhinitis-related health-related quality of life in children with uncontrolled persistent asthma with comorbid allergic rhinitis

Alessandro FiocchiWanda PhipatanakulSandy DurraniJeremy ColeDongfang LiuJérôme MsihidDavid LedererMegan HardinYi ZhangAsif H. Khan

Dupilumab improves health related quality of life : results from the phase 3 SINUS studies

Stella E LeeClaire HopkinsJoaquim MullolJérôme MsihidIsabelle GuilleminNikhil AminLeda P MannentYongtao LiShahid SiddiquiChien Chia Chuang et al.

A1 Artikel in een tijdschrift in ALLERGY

Dupilumab improves health-related quality of life : results from the phase 3 SINUS studies

Stella E LeeClaire HopkinsJoaquim MullolJérôme MsihidIsabelle GuilleminNikhil AminLeda P MannentYongtao LiShahid SiddiquiChien-Chia Chuang et al.

A1 Artikel in een tijdschrift in ALLERGY

Dupilumab improves objective, subjective, and health-related quality of life outcomes in chronic rhinosinusitis with nasal polyps (CRSwNP), regardless of BMI≥ 30 kg/m2 or weight≥ 90 kg : post-hoc analysis of the SINUS-24 and SINUS-52 studies

Seong ChoBruce TanNoam CohenJody TverskyElina ToskalaScott NashHaixing ZhangShahid SiddiquiAsif H. KhanJuby Jacob-Nara et al.

Dupilumab leads to reduction of anosmia in patients with severe chronic rhinosinusitis with nasal polyps

Andrew LaneJoaquim MullolClaire HopkinsWytske FokkensStella LeeAsif H. KhanJérôme MsihidScott NashShahid SiddiquiUrvi Mujumdar et al.

Dupilumab reduces asthma disease burden and recurrent SCS use in patients with CRSwNP and coexisting asthma

Mark GurnellAndrew Menzies-GowClaus BachertNjira LugogoSeong ChoShahid SiddiquiScott NashHaixin ZhangAsif H. KhanJuby Jacob Nara et al.

Evaluating treatment responses of dupilumab versus omalizumab in type 2 patients : the EVEREST trial

Lucia de Prado GomezAsif H. KhanAnju PetersClaus BachertMartin WagenmannEnrico HefflerClaire HopkinsPeter HellingsMei ZhangJun Xing et al.

Impact of dupilumab on SNOT-22 sleep and function scores in CRSwNP

William W. BusseAndrew WellmanZuzana DiamantNoam A. CohenAdam M. ChakerClaus BachertShahid SiddiquiHaixin ZhangScott NashAsif H. Khan et al.

A1 Artikel in een tijdschrift in JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE) : an open-label extension study

Michael E WechslerLinda B FordJorge F MasperoIan D PavordAlberto PapiArnaud BourdinHenrik WatzMario CastroNatalia M NenashevaYuji Tohda et al.

A1 Artikel in een tijdschrift in LANCET RESPIRATORY MEDICINE

Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps

Joaquim MullolClaus BachertNikhil AminMartin DesrosiersPeter W HellingsJoseph K HanRoger JankowskiJan VodickaPhilippe GevaertNadia Daizadeh et al.

A1 Artikel in een tijdschrift in JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma

Eric D BatemanAsif H. KhanYingxin XuPatricia GuyotJingdong ChaoSiddhesh KamatPaul RoweHeather BurnettJerome MsihidDavid Weinreich

A1 Artikel in een tijdschrift in RESPIRATORY MEDICINE

Rapid and continuing improvements in nasal symptoms with dupilumab in patients with severe CRSwNP

Claus BachertAsif H. KhanClaire HopkinsMichael S. BlaissZachary M. SolerScott NashShahid SiddiquiAmy PraestgaardYamo DenizPaul J. Rowe et al.

A1 Artikel in een tijdschrift in JOURNAL OF ASTHMA AND ALLERGY

Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps

Peter HellingsAnju T PetersAdam M ChakerEnrico HefflerHaixin ZhangAmy PraestgaardScott NashAsif H. KhanShahid SiddiquiJuby A Jacob-Nara et al.

Redactioneel materiaal

Response to comment on : Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020)

Eric D BatemanAsif H. KhanYingxin XuPatricia GuyotJingdong ChaoSiddhesh KamatHeather BurnettJerome MsihidDavid M WeinreichIan Pavord

A1 Artikel in een tijdschrift in RESPIRATORY MEDICINE

Response to the correspondence : 'Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma'

Eric D BatemanAsif H. KhanYingxin XuPatricia GuyotPaul RoweHeather BurnettJerome MsihidDavid WeinreichIan Pavord

A1 Artikel in een tijdschrift in RESPIRATORY MEDICINE

Symptom free days in patients with severe chronic rhinosinusitis with nasal polyps treated with dupilumab

Claus BachertClaire HopkinsJoseph HanWytske FokkensLeda MannentAsif H. KhanJerome MsihidUrvi MujumdarSiddhesh KamatScott Nash et al.

2021

Association between dupilumab effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS-24 and SINUS-52 trials

Claus BachertJ CorrenSE LeeH ZhangS HarelD CunoosamyAsif H. KhanJA Jacob-NaraS SiddiquiS Nash

Dupilumab efficacy and safety in children with uncontrolled, moderate-to-severe asthma : the phase 3 VOYAGE study

LB BacharierJF MasperoCH KatelarisAG FiocchiR GagnonI de MirN JainLD SherX MaoD. Liu et al.

Dupilumab efficacy vs standard of care in patients with uncontrolled, persistent asthma–a meta analysis

ID PavordAsif H. KhanB NeupaneP GuyotS KamatJ ChaoP RoweJ MsihidY Xu

Dupilumab improves CRSWNP/asthma outcomes in patients with CRSWNP and comorbid asthma irrespective of asthma characteristics

W BusseI PavordS SiddiquiAsif H. KhanA PraestgaardS NashJ Jacob-NaraP RoweY Deniz

Dupilumab improves asthma control and quality of life in children with uncontrolled persistent asthma

Alessandro FiocchiWanda PhipatanakulSandy R DurraniJeremy ColeXuezhou MaoJérôme MsihidDavid J LedererMegan HardinYi ZhangAsif H. Khan

Dupilumab in children with uncontrolled moderate-to-severe asthma

Leonard B BacharierJorge F MasperoConstance H KatelarisAlessandro G FiocchiRemi GagnonInes de MirNeal JainLawrence D SherXuezhou MaoD. Liu et al.

A1 Artikel in een tijdschrift in NEW ENGLAND JOURNAL OF MEDICINE

Dupilumab leads to clinical asthma remission indicative of comprehensive improvement in patients with asthma

I PavordW BusseE IsraelS SzeflerZ ChenAsif H. KhanD LedererY Zhang

Dupilumab provides early and durable improvement of symptoms in patients with chronic rhinosinusitis with nasal polyps : results from the SINUS-24 and SINUS-52 phase 3 trials

Philippe GevaertSE LeeR SettipaneM WagenmannJ MsihidS SiddiquiS NashJA Jacob-NaraAsif H. KhanS Kamat et al.

Dupilumab reduces systemic corticosteroid use and sinonasal surgery rate in CRSwNP

M. DesrosiersL.P. MannentN. AminG.W. CanonicaPeter HellingsPhilippe GevaertJ. MullolS.E. LeeS. FujiedaJ.K. Han et al.

A1 Artikel in een tijdschrift in RHINOLOGY

Dupilumab shows sustained efficacy and improvements in asthma control and health-related quality of life in patients with moderate-to-severe asthma : liberty asthma traverse

M WechslerLB FordJF MasperoID PavordD LangtonC DomingoA PapiA BourdinH WatzX. Mao et al.

Dupilumab treatment leads to clinical asthma remission in patients with uncontrolled moderate-to-severe asthma with type 2 inflafmmation

Ian PavordWilliam BusseElliot IsraelStanley SzeflerZhen ChenNadia DaizadehDavid LedererLeda MannentNikhil AminElizabeth Laws et al.

Effect of dupilumab on improving physical activity in patients with severe asthma

Lawrence SherSantiago QuirceGiovanni PassalacquaCamille TailléLauren CohnNadia DaizadehNami Pandit-AbidBenjamin OrtizAsif H. KhanYi Zhang

Effect of dupilumab on patient-reported sleep outcomes in patients with severe asthma

Lawrence SherGiovanni PassalacquaCamille TailléLauren CohnSantiago QuirceNadia DaizadehNami Pandit-AbidBenjamin OrtizAsif H. KhanYi Zhang

Efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps and allergic rhinitis

A PetersM WagenmannJA BernsteinH ZhangAsif H. KhanS NashJA Jacob-NaraS Siddiqui

Health-related quality of life impairment among patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 trial

Jorge MasperoCarl PhilpottPeter HellingsClaire HopkinsMartin WagenmannShahid SiddiquiJuby Jacob-NaraJerome MsihidChien-Chia ChuangSiddhesh Kamat et al.

Impact of dupilumab on sleep/function scores in patients with chronic rhinosinusitis with nasal polyps

W BusseA WellmanClaus BachertS SiddiquiH ZhangAsif H. KhanJ Jacob-NaraP RoweY Deniz

Improvement in patient-reported ’taste’ and association with smell in dupilumab-treated severe chronic rhinosinusitis with nasal polyps patients from the SINUS-24 and SINUS-52 trials

AT PetersZM SolerKern RcE HefflerJF MasperoL CrampetteS FujiedaAP LaneH ZhangS. Nash et al.

Liberty asthma traverse dupilumab shows sustained efficacy and improvements in asthma control and health-related quality of life (HRQOL) in patients with moderate-to-severe asthma

M WechslerLB FordJF MasperoID PavordD LangtonC DomingoA PapiA BourdinH WatzX. Mao et al.

Long-term efficacy of dupilumab in patients with moderate-to-severe asthma in the liberty asthma traverse open-label extension study : improvements in asthma control and health-related quality of life

ID PavordME WechslerLB FordJF MasperoD LangtonC DomingoA PapiA BourdinH WatzX. Mao et al.

Rapid and sustained effects of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps : analysis of the SINUS-24 and SINUS-52 phase 3 trails

Peter HellingsA PetersAM ChakerE HefflerH ZhangN DaizadehS NashAsif H. KhanS SiddiquiJA Jacob-Nara

Reducing fungal exposure critical for treating rhinosinusitis with or without polyps [response to letter]

Claus BachertNeil BhattacharyyaMartin DesrosiersAsif H. Khan

A1 Artikel in een tijdschrift in JOURNAL OF ASTHMA AND ALLERGY

SNOT-22 items and association with objective measures in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from SINUS-24 and SINUS-52 trials

Joaquim MullolGiorgio Walter CanonicaMartin WagenmannAndre CostePeter HellingsScott NashSiddhesh KamatUrvi MujumdarJérôme MsihidAsif H. Khan et al.

2020

A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study

JF MasperoP KunaLB FordA Valero SantiagoN DaizadehP RoweY DenizS KamatAsif H. KhanN Pandit-Abid et al.

Association between asthma severity, quality of life, and productivity in France, Germany, Italy, Spain, and the United Kingdom

Asif H. KhanNikoletta SternbachSiddhesh KamatKathy AnnunziataDena JaffeImène Gouia

Availability of fractional exhaled nitric oxide (FeNO) and eosinophil (EOS) count data among patients with severe asthma in five European countries

Siddhesh KamatImène GouiaJingdong ChaoMark SmallAsif H. KhanJames Siddall

Dupilumab efficacy in patients with uncontrolled, moderate-to-severe allergic asthma

Jonathan CorrenMario CastroThomas O’RiordanNicola A HananiaIan D PavordSantiago QuirceBradley E ChippsSally E WenzelKarthinathan ThangaveluMegan S Rice et al.

A1 Artikel in een tijdschrift in JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

Dupilumab efficacy in uncontrolled, moderate-to-severe asthma with self-reported chronic rhinosinusitis

Jorge F MasperoConstance H KatelarisWilliam W BusseMario CastroJonathan CorrenBradley E ChippsAnju T PetersIan D PavordLinda B FordLawrence Sher et al.

A1 Artikel in een tijdschrift in JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

Dupilumab improves asthma control as assessed by total and individual item scores of the 6-item asthma control questionnaire in patients with severe chronic rhinosinusitis with nasal polyps and comorbid asthma : pooled results from the SINUS-24 and SINUS-52 phase 3 studies

Claus BachertJK HanM DesrosiersPW HellingsX MaoM ZhangN AminLP MannentS KamatAsif H. Khan

Dupilumab improves patient-reported breathing in oral corticosteroid-dependent severe asthma

Lawrence SherRobert WolfeSantiago QuirceLauren CohnGiovanni PassalacquaPierluigi PaggiaroCamille TailléNadia DaizadehBenjamin OrtizNami Pandit-Abid et al.

Dupilumab rapidly improves sense of smell in patients with severe chronic rhinosinusitis with nasal polyps : pooled results from the SINUS-24 and SINUS-52 phase 3 studies

J. MullolClaus BachertM. DesrosiersJ. K. HanR. JankowskiN. DaizadehN. AminL. P. MannentAsif H. KhanS. Kamat

Dupilumab reduced severe exacerbations and improved lung function in patients with uncontrolled, moderate-to-severe asthma with an eosinophilic phenotype across baseline IgE levels : LIBERTY ASTHMA QUEST study

WW CarrJ CorrenTB CasaleN DaizadehAsif H. KhanS KamatY DenizP Rowe

Dupilumab reduces severe outpatient asthma exacerbations, cumulative dose, and total number of days of systemic corticosteroid use among patients with moderate-to-severe type-2 asthma

Giorgio Walter CanonicaRobert ZeigerMario CastroJerome MsihidBenjamin OrtizNami Pandit-AbidSiddhesh KamatAsif H. Khan

Effect of Dupilumab on patient-reported breathing and rescue medication use

Jonathan CorrenMario CastroJorge F MasperoWilliam W BusseAntonio Valero SantiagoPiotr KunaNadia DaizadehNami Pandit-AbidBenjamin OrtizAsif H. Khan et al.

Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis

William W BusseJorge F MasperoYufang LuJonathan CorrenNicola A HananiaBradley E ChippsConstance H KatelarisJ Mark FitzGeraldSantiago QuirceLinda B Ford et al.

A1 Artikel in een tijdschrift in ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Meta-analyses of dupilumab versus standard of care in patients with uncontrolled, persistent asthma

ID PavordAsif H. KhanB NeupaneP GuyotS KamatJ ChaoP RoweJ MsihidY Xu

Prevalence of asthma in France, Germany, Italy, Spain, and the United Kingdom, based on the 2018 European National Health and Wellness survey

Asif H. KhanNikoletta SternbachSiddhesh KamatKathy AnnunziataDena JaffeImène Gouia

Type 2 inflammation-related comorbidities among patients with asthma, chronic rhinosinusitis with nasal polyps, and atopic dermatitis

Asif H. KhanImène GouiaSiddhesh KamatBenjamin OrtizRobert JohnsonJames SiddallMark Small

2019

Baseline characteristics of patients with chronic rhinosinusitis with nasal polyps (with and without asthma) enrolled in SINUS-52 : a randomized, double-blind, phase 3 study of dupilumab

Claus BachertM DesrosiersJ MullolJF MasperoM WagenmannI NiemannAsif H. KhanS KamatN AminLP Mannent

Baseline-Charakteristika von Patienten mit chronischer Rhinosinusitis mit nasalen Polypen (mit und ohne Asthma) in SINUS-52 : einer randomisierten, doppel-blinden, Phase-3-Studie von Dupilumab

Claus BachertM DesrosiersJ MullolJF MasperoM WagenmannI NiemannAsif H. KhanS KamatN AminLP Mannent

Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps

Neil BhattacharyyaSara VilleneuveVijay N JoishCaroline AmandLeda MannentNikhil AminPaul RoweJaman MaroniLaurent EckertTony Yang et al.

A1 Artikel in een tijdschrift in LARYNGOSCOPE

Dupilumab consistently improves rhinoconjunctivitis-specific health-related quality of life in patients with uncontrolled, moderate-to-severe asthma and comorbid allergic rhinitis : results from the phase 3 LIBERTY ASTHMA QUEST study

Jean BousquetJorge F MasperoBradley E ChippsJonathan CorrenJ Mark FitzGeraldZhen ChenYufang LuPaul RoweHeribert StaudingerMarcella Ruddy et al.

Dupilumab improved asthma control across baseline immunoglobulin E levels : liberty asthma quest study

W CarrJ CorrenM RiceY DenizP RoweA TeperAsif H. KhanS Kamat

Dupilumab improved asthma control and health-related quality of life in patients with oral-corticosteroid-dependent severe asthma in the phase 3 LIBERTY ASTHMA VENTURE study

LB FordKF RabeRN WolfeS QuirceMS RiceP RoweY LuS KamatN AminN.M.H. Graham et al.

Dupilumab improved asthma control in patients with uncontrolled, moderate-to-severe asthma, regardless of exacerbations in the previous year

Stephanie KornJonathan CorrenMario CastroJ MasperoZhen ChenIna NiemannSiddhesh KamatNikhil AminAriel TeperAsif H. Khan

Dupilumab improved morning and evening daily asthma symptoms in patients with oral-corticosteroid-dependent severe asthma in the phase 3 LIBERTY ASTHMA VENTURE study

L SherKF RabeRN WolfeS QuirceMS RiceP RoweY LuS KamatN. AminNMH Graham et al.

Dupilumab improves asthma outcomes irrespective of frequency of previous asthma exacerbation history

Jonathan CorrenMario CastroLinda B FordJonathan A BernsteinShyamalie JayawardenaJaman MaroniPaul RoweNikhil AminGianluca PirozziNeil M.H. Graham et al.

A1 Artikel in een tijdschrift in ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Dupilumab improves health-related quality of life in patients with oral corticosteroid-dependent, severe asthma with comorbid chronic rhinosinusitis with and without nasal polyps

JF MasperoKF RabeM CastroMS RiceP RoweY DenizN AminS KamatA TeperAsif H. Khan

Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD

Tanya M LaidlawJoaquim MullolChunpeng FanDonghui ZhangNikhil AminAsif H. KhanJingdong ChaoLeda P Mannent

A1 Artikel in een tijdschrift in JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

The GALEN rhinosinusitis cohort : chronic rhinosinusitis with nasal polyps affects health-related quality of life

Asif H. KhanThi Minh Thao HuynhGRIET VANDEPLASVijay N JoishLeda P MannentPeter TomassenThibaut Van ZeleLars-Olaf CardellJulia ArebroHeidi Olze et al.

A1 Artikel in een tijdschrift in RHINOLOGY

The Global Allergy and Asthma European Network (GALEN) rhinosinusitis cohort : a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps

Asif H. KhanGRIET VANDEPLASThi Minh Thao HuynhVijay N. JoishLeda MannentPeter TomassenThibaut Van ZeleLars-Olaf CardellJulia ArebroHeidi Olze et al.

A1 Artikel in een tijdschrift in RHINOLOGY

2018

A randomized, controlled phase 3 study, LIBERTY ASTHMA QUEST, evaluating the efficacy and safety of dupilumab in uncontrolled moderate-to-severe asthma

M CastroJ CorrenID PavordJF MasperoSE WenzelKF RabeWW BusseLB FordL SherJ. FitzGerald et al.

Dupilumab demonstrates rapid and sustained improvements in daily asthma-related symptoms in patients with uncontrolled, moderate-to-severe asthma : data from the Liberty Asthma Quest study

Jo DouglassDavid LangtonJonathan CorrenMario CastroSophie GuillonneauJingdong ChaoNikhil AminNeil MH GrahamAriel TeperAsif H. Khan

Dupilumab improves ACQ-5 items in CRSwNP patients with comorbid asthma

Peter HellingsClaus BachertJ MullolD HamilosR NaclerioL MannentN AminC TaniouG PirozziN. Graham et al.

Dupilumab improves SNOT-22 scores in asthma patients with chronic rhinosinusitis or nasal polypsosis (CRS/NP) in LIBERTY ASTHMA QUEST

William BusseJorge F MasperoContance H KatelarisDinesh SaralayaSophie GuillonneauBingzhi ZhangChristine TaniouHeribert StaudingerJingdong ChaoNikhil Amin et al.

Dupilumab improves asthma control in patients with uncontrolled, moderate-to-severe asthma, regardless of exacerbation history

Jonathan CorrenMario CastroJ MasperoB CosioPiotr KunaZhen ChenHeribert StaudingerJingdong ChaoA NikhilMarcella Ruddy et al.

Dupilumab improves asthma-related patient reported outcomes in asthma patients with chronic rhinosinusitis or nasal polyposis (CRS/NP) in LIBERTY ASTHMA QUEST

Jonathan CorrenMario CastroJorge F MasperoAntonio L Valero SantiagoPiotr KunaSophie GuillonneauQunming DongChristine TaniouHeribert StaudingerJingdong Chao et al.

Dupilumab improves health related quality of life in uncontrolled, moderate-to-severe asthma patients with comorbid allergic rhinitis from the phase 3 LIBERTY ASTHMA QUEST study

J MasperoWW BusseCH KatelarisA YanezS GuillonneauZ ChenH StaudingerJ ChaoN AminG. Pirozzi et al.

Dupilumab improves mental health measures in patients with chronic rhinosinusitis and nasal polyposis (CRSwNP)

Claus BachertRobert NaclerioPeter HellingsSophie GuillonneauChristine TaniouJaman MaroniPaul RoweLeda MannentNikhil AminSiddesh Kamat et al.

Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and NSAID-ERD

J MullolTM LaidlawQ DongC FanD ZhangN AminAsif H. KhanJ ChaoL Mannent

Dupilumab in patients with corticosteroid-dependent severe asthma : efficacy and safety results from the randomized, double-blind, placebo-controlled phase 3 LIBERTY ASTHMA VENTURE study

KF RabePK NairGuy BrusselleJF MasperoM CastroH ZhuH StaudingerG PirozziC AntoniN. Amin et al.

Dupilumab produces rapid and sustained improvements in asthma-related symptoms in patients with uncontrolled, moderate-to-severe asthma from the LIBERTY ASTHMA QUEST study

J CorrenM CastroS GuillonneauJ ChaoN AminG PirozziNMH GrahamA TeperAsif H. Khan

Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma

Klaus F RabeParameswaran NairGuy BrusselleJorge F MasperoMario CastroLawrence SherHongjie ZhuJennifer D HamiltonBrian N SwansonAsif H. Khan et al.

A1 Artikel in een tijdschrift in NEW ENGLAND JOURNAL OF MEDICINE

Eosinophil levels, exacerbations, resource utilization and costs among moderate-to-severe asthma patients

J GrahamJ ChaoU MallyaAsif H. KhanS KamatP Simonelli

Impact of baseline eosinophils on future exacerbations in patients with moderate-to-severe asthma

Asif H. KhanS KamatL EckertC AmandP RoweA TeperJ MaroniB JonesT BerniC Morgan

Impact of chronic rhinosinusitis with nasal polyposis on quality of life by sino-nasal surgery history

Asif H. KhanT HuynhS KamatL MannentPeter TomassenThibaut Van ZeleLars-Olaf CardellJ ArebroH OlzeU Foerster-Ruhrmann et al.

2017

Dupilumab improves all ACQ-5 individual items in patients with chronic rhinosinusitis with nasal polyposis (CRSwNP) and asthma : results from a phase 2a trial

Peter HellingsClaus BachertJoaquim MullolDaniel HamilosRobert NaclerioVijay JoishLeda MannentNikhil AminAdeline AbbeChristine Taniou et al.

Dupilumab improves sense of smell and reduces anosmia among patients with nasal polyposis and chronic sinusitis : results from a phase 2a trial

Robert M. NaclerioDaniel L. HamilosBerrylin J. FergusonClaus BachertPeter W. HellingsJoaquim MullolPhilippe GevaertDonghui ZhangAsif H. KhanChunpeng Fan et al.

Impact of exacerbations on lung function in patients with asthma

Juan P WisniveskyEmily GoodmanErin WestNikhil AminVijay JoishSara VilleneuveLaurent EckertAriel TeperAsif H. Khan

2016

Dupilumab improves health-related quality of life and absenteeism in nasal polyposis patients : results from a phase 2a trial

Claus BachertP HellingsJ MullolD HamilosR NaclerioVN JoishL MannentR EvansA AbbeC. Amand et al.

Dupilumab improves patient-reported outcomes in chronic sinusitis with nasal polyps patients with comorbid asthma : results from a phase 2a trial

Claus BachertPeter HellingsJoaquim MullolDaniel HamilosRobert NaclerioVijay N JoishLeda MannentRobert E EvansAnnette GrabherAdeline Abbe et al.

2015

The ‘GA^2LEN sinusitis cohort’ : an introduction

GRIET VANDEPLASAsif H. KhanThi Minh Thao HuynhPeter TomassenThibaut Van ZeleLars-Olaf CardellJulia ArebroHeidi OlzeUlrike FoersterMarek Leszek Kowalski et al.